pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›HB-adMSCs
drug
save

HB-adMSCs

Phase 3updated 3mo ago
by Hope Biosciences LLC
Phase 3
community read0 votes

indications

indications
Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying HB-adMSCs

  • phase2Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injuryrecruitingn=51
  • phase2HB-adMSCs for the Treatment of Crohn's Diseaserecruitingn=46
  • —"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."available
  • phase2Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)completedn=24
  • phase2Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injuryrecruitingn=70
  • phase2A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathycompletedn=24
  • phase2Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)completedn=60
  • phase2"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"active not recruitingn=10
more trials →

News(0)

no news has mentioned this drug yet

indication
Spinal Cord Injury
phase
phase_3
Data sources
ClinicalTrials.gov
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?